Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AHR | P35869 | 1/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.34 |
| ▸ | ATM | Q13315 | 1/20 | 0.34 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.34 |
| ▸ | KIF11 | P52732 | 4/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | GPR3 | P46089 | 1/20 | 0.31 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.31 |
| ▸ | TOP2A | P11388 | 1/20 | 0.31 |
| ▸ | TNKS | O95271 | 1/20 | 0.30 |
| ▸ | TNKS2 | Q9H2K2 | 1/20 | 0.30 |
| ▸ | MMP2 | P08253 | 1/20 | 0.30 |
| ▸ | MMP9 | P14780 | 1/20 | 0.30 |
| ▸ | MMP8 | P22894 | 1/20 | 0.30 |
| ▸ | MMP13 | P45452 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19320154 | 0.92 | AHR (0.39) | AHRKDM4EATML3MBTL1KIF11 | |
| SCHEMBL17548846 | 0.92 | AHR (0.41) | AHRKDM4EATML3MBTL1KIF11 | |
| SCHEMBL19320151 | 0.90 | KDM4E (0.45) | AHRKDM4EATML3MBTL1KIF11 | |
| SCHEMBL19320139 | 0.89 | KDM4E (0.37) | AHRKDM4EATML3MBTL1KIF11 | |
| SCHEMBL19320143 | 0.89 | AHR (0.39) | AHRKDM4EATML3MBTL1KIF11 | |
| SCHEMBL19320160 | 0.87 | AHR (0.40) | AHRKDM4EATML3MBTL1KIF11 | |
| SCHEMBL25679748 | 0.86 | KDM4E (0.46) | AHRKDM4EATML3MBTL1KIF11 | |
| SCHEMBL16999819 | 0.86 | KDM4E (0.46) | AHRKDM4EATML3MBTL1KIF11 | |
| SCHEMBL10014523 | 0.86 | L3MBTL1 (0.41) | KDM4EATML3MBTL1ALDH1A1GPR3 | |
| SCHEMBL19320114 | 0.85 | MEN1 (0.41) | KDM4EATML3MBTL1KIF11TNKS |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10381574-B2 | Compound for organic electronic element, organic electrical element using compound, and electronic device comprising same | DUK SAN NEOLUX CO., LTD. (KR) | 2019-08-13 | — | — | US | disclosed |
| US-20190103561-A1 | Compound For Organic Electronic Element, Organic Electrical Element Using Compound, And Electronic Device Comprising Same | DUK SAN NEOLUX CO., LTD (KR) | 2019-04-04 | — | — | US | disclosed |
| US-20170256719-A1 | COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRICAL ELEMENT USING COMPOUND, AND ELECTRONIC DEVICE COMPRISING SAME | DUK SAN NEOLUX CO., LTD (KR) | 2017-09-07 | — | — | US | disclosed |
| US-20170256719-A1 | COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRICAL ELEMENT USING COMPOUND, AND ELECTRONIC DEVICE COMPRISING SAME | DUK SAN NEOLUX CO., LTD (KR) | 2017-09-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170256719-A1 | COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRICAL ELEMENT USING COMPOUND, AND ELECTRONIC DEVICE COMPRISING SAME | ORAI2, VDAC2, PIEZO1 | AHR 765/4885KDM4E 594/4885ATM 2903/4885 |
| US-20190103561-A1 | Compound For Organic Electronic Element, Organic Electrical Element Using Compound, And Electronic Device Comprising Same | ORAI2, VDAC2, PIEZO1 | AHR 765/4885KDM4E 594/4885ATM 2903/4885 |
| US-10381574-B2 | Compound for organic electronic element, organic electrical element using compound, and electronic device comprising same | ORAI2, VDAC2, PIEZO1 | AHR 765/4885KDM4E 594/4885ATM 2903/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.